Yalamanchili, K.; Broadwin, M.; Harris, D.D.; Teixeira, R.B.; Sellke, F.W.; Wipf, P.; Abid, M.R.
Targeting Mitochondrial Reactive Oxygen Species: JP4-039’s Potential as a Cardiovascular Therapeutic. J. Clin. Med. 2025, 14, 6465.
https://doi.org/10.3390/jcm14186465
AMA Style
Yalamanchili K, Broadwin M, Harris DD, Teixeira RB, Sellke FW, Wipf P, Abid MR.
Targeting Mitochondrial Reactive Oxygen Species: JP4-039’s Potential as a Cardiovascular Therapeutic. Journal of Clinical Medicine. 2025; 14(18):6465.
https://doi.org/10.3390/jcm14186465
Chicago/Turabian Style
Yalamanchili, Keertana, Mark Broadwin, Dwight D. Harris, Rayane B. Teixeira, Frank W. Sellke, Peter Wipf, and M. Ruhul Abid.
2025. "Targeting Mitochondrial Reactive Oxygen Species: JP4-039’s Potential as a Cardiovascular Therapeutic" Journal of Clinical Medicine 14, no. 18: 6465.
https://doi.org/10.3390/jcm14186465
APA Style
Yalamanchili, K., Broadwin, M., Harris, D. D., Teixeira, R. B., Sellke, F. W., Wipf, P., & Abid, M. R.
(2025). Targeting Mitochondrial Reactive Oxygen Species: JP4-039’s Potential as a Cardiovascular Therapeutic. Journal of Clinical Medicine, 14(18), 6465.
https://doi.org/10.3390/jcm14186465
